Browse our anti-Leucine Rich Repeat Containing 4 (LRRC4) Antibodies

Full name:
anti-Leucine Rich Repeat Containing 4 Antibodies (LRRC4)
On www.antibodies-online.com are 26 Leucine Rich Repeat Containing 4 (LRRC4) Antibodies from 10 different suppliers available. Additionally we are shipping Leucine Rich Repeat Containing 4 Proteins (10) and Leucine Rich Repeat Containing 4 Kits (1) and many more products for this protein. A total of 38 Leucine Rich Repeat Containing 4 products are currently listed.
Synonyms:
MBAG1, Nag14, NGL-2, NLG-2
list all antibodies Gene Name GeneID UniProt
LRRC4 64101 Q9HBW1
LRRC4 192198 Q99PH1
LRRC4 641521 Q45R42

Show all species

Show all synonyms

Most Popular Reactivities for anti-Leucine Rich Repeat Containing 4 (LRRC4) Antibodies

Select your species and application

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-Leucine Rich Repeat Containing 4 Antibodies

Go to our pre-filtered search.

Top referenced anti-Leucine Rich Repeat Containing 4 Antibodies

  1. Human Polyclonal LRRC4 Primary Antibody for EIA, IHC (p) - ABIN953221 : Wu, Huang, Li, Li, Gan, Chen, Tang, Tang, Shen, Li: LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses. in Journal of cellular physiology 2007 (PubMed)
    Show all 5 references for 953221

  2. Human Polyclonal LRRC4 Primary Antibody for IHC (p), WB - ABIN653483 : Wu, Huang, Gan, Huang, Chen, Ouyang, Tang, Li, Yang, Zhou, Zhou, Zeng, Xiao, Li, Tang, Shen, Li: LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathway. in Molecular biology of the cell 2006 (PubMed)
    Show all 3 references for 653483

More Antibodies against Leucine Rich Repeat Containing 4 Interaction Partners

Human Leucine Rich Repeat Containing 4 (LRRC4) interaction partners

  1. polymorphisms and haplotypes in the LRRC4 may have a role in pituitary adenoma in a Chinese population

  2. Disturbing miR (show MLXIP Antibodies)-182 and -381 inhibits BRD7 (show BRD7 Antibodies) transcription and glioma growth by directly targeting LRRC4.

  3. LRRC4 inhibited the miR (show MLXIP Antibodies)-185 pathway function in glioma

  4. Potentially, modulation of LRRC4 or STMN1 (show STMN1 Antibodies) expression may be useful for design of new therapies for the intervention of glioma

  5. As a glioma suppressor, LRRC4 inhibits the endogenous expression of small regulatory microRNA hsa (show CD24 Antibodies)-miR (show MLXIP Antibodies)-381 and decreases cell proliferation and tumor growth in cultured glioma cells.

  6. LRRC4 may play an important role in maintaining normal function and suppressing tumorigenesis in the central nervous system.

  7. LRRC4 gene might be involved in tumor suppression by restraining DNA synthesis and nucleoli organizer regions-associated proteins.

  8. these studies represent the first cDNA array analysis of the effects of LRRC4 on the involvement of different neurobiological genes in U251MG glioblastoma cells and provide new insights into the function of LRRC4 in glioma

  9. LRRC4 plays a major role in suppressing U251 cell proliferation by regulating the extracellular signal-regulated kinase (ERK (show EPHB2 Antibodies))/Akt (show AKT1 Antibodies)/NF-kappaBp65, STAT3 (show STAT3 Antibodies), and JNK2 (show MAPK9 Antibodies)/c-Jun (show JUN Antibodies) pathways.

  10. LRRC4 may be a negative regulator of the RPTP-zeta (show PTPRZ1 Antibodies) receptor, and contribute to suppressing the invasion ability of gliomas cells

Mouse (Murine) Leucine Rich Repeat Containing 4 (LRRC4) interaction partners

  1. our results identify NGL-2 as a central component of pathway-specific development in the outer retina.

  2. These results demonstrate that NGL-2 is critical for pathway-specific synapse development and functional integration of distinct inputs.

  3. LRRC4 may play an important role in maintaining normal function and suppressing tumorigenesis in the central nervous system.

  4. Together, these findings provide clues to the function of LRRC4 as a negative regulator of cell growth and underscore a link between the above-mentioned cyclins, cyclin (show PCNA Antibodies)-associated molecules and tumorigenicity.

Leucine Rich Repeat Containing 4 (LRRC4) Antigen Profile

Antigen Summary

This gene is significantly downregulated in primary brain tumors. The exact function of the protein encoded by this gene is unknown.

Alternative names and synonyms associated with Leucine Rich Repeat Containing 4 (LRRC4)

  • leucine rich repeat containing 4 (LRRC4) antibody
  • leucine rich repeat containing 4 (Lrrc4) antibody
  • MBAG1 antibody
  • Nag14 antibody
  • NGL-2 antibody
  • NLG-2 antibody

Protein level used designations for LRRC4

brain tumor associated protein LRRC4 , brain tumor-associated protein BAG , leucine-rich repeat-containing 4 , leucine-rich repeat-containing protein 4 , nasopharyngeal carcinoma-associated gene 14 protein , netrin-G2 ligand , leucine rich repeat containing 4 protein , netrin-G1 ligand , LIBG-like protein , LRRC4-like protein , brain tumor-associated protein MBAG1 , NGL-2 , protein NGL-2

GENE ID SPECIES
100056742 Equus caballus
64101 Homo sapiens
607997 Canis lupus familiaris
525767 Bos taurus
192198 Mus musculus
641521 Rattus norvegicus
Selected quality suppliers for anti-Leucine Rich Repeat Containing 4 (LRRC4) Antibodies
Did you look for something else?